P. Skarman

Induction of polymorphonuclear leukocyte response by human cytomegalovirus.

A. Rahbar, C. Söderberg-Nauclér, Xun Xie, 2006, Microbes and infection.

Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients

G. Stragliotto, Xinling Xu, C. Taher, 2016, Oncoimmunology.

Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery

G. Stragliotto, A. Rahbar, C. Söderberg-Nauclér, 2015, Oncoimmunology.

Effects of valganciclovir as an add‐on therapy in patients with cytomegalovirus‐positive glioblastoma: A randomized, double‐blind, hypothesis‐generating study

G. Stragliotto, A. Lilja, C. Taher, 2013, International journal of cancer.

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV

G. Stragliotto, Xinling Xu, A. Assinger, 2015, Oncoimmunology.

Selective Inhibition of IgG-Mediated Phagocytosis in Gelsolin-Deficient Murine Neutrophils1

K. Krause, W. Witke, D. Lew, 2000, The Journal of Immunology.

NeutrophilsPhagocytosis in Gelsolin-Deficient Murine Selective Inhibition of IgG-Mediated

K. Krause, D. Lew, O. Stendahl, 2000 .